MUC1 and non-small cell lung carcinoma: In addition, Pan et al recently have developed an anti‐MUC1 antibody‐drug conjugate synthesized by conjugating GSTA neoantigen‐specific 16A with monomethyl auristatin E (MMAE), which displaying potent antitumoural efficacy towards various cancer cells including NSCLC.39